Cargando…
Prognostic value of the pretreatment systemic immune-inflammation index in patients with prostate cancer: a systematic review and meta-analysis
BACKGROUND: The systemic immune-inflammation index (SII) is a novel biomarker to predict the prognosis of some malignant tumors based on neutrophil, platelet, and lymphocyte counts. Evidence is scarce about the prognostic value of SII for prostate cancer patients. This systematic review and meta-ana...
Autores principales: | Meng, Linghao, Yang, Yujia, Hu, Xu, Zhang, Ruohan, Li, Xiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898902/ https://www.ncbi.nlm.nih.gov/pubmed/36739407 http://dx.doi.org/10.1186/s12967-023-03924-y |
Ejemplares similares
-
Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Gastric Cancer: A Meta-Analysis
por: Qiu, Ye, et al.
Publicado: (2021) -
Prognostic Value of the Pretreatment Systemic Immune-Inflammation Index in Patients with Colorectal Cancer
por: Li, Jing, et al.
Publicado: (2020) -
Prognostic significance of pretreatment systemic immune-inflammation index in patients with prostate cancer: a meta-analysis
por: Zhang, Buwen, et al.
Publicado: (2023) -
Prognostic role of the pretreatment systemic immune-inflammation index in patients with glioma: A meta-analysis
por: Zhang, Sunhuan, et al.
Publicado: (2023) -
Prognostic value of Systemic immune-inflammation index in cancer: A meta-analysis
por: Yang, Ruonan, et al.
Publicado: (2018)